butabarbital decreases outcomes of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers could lessen sufentanil stages and efficacy, possibly precipitating withdrawal syndrome in patients who may have developed Bodily dependence to sufentanil. Discontinu